Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Health
Robyn Wuth

Deal spares MS patients $33k annually in medicine costs

MS sufferers and their supporters have welcomed news from the federal government about medicines. (James Ross/AAP PHOTOS)

Thousands of Australians with multiple sclerosis have been spared paying $33,000 a year for treatment after the federal government struck a deal to keep life-changing drugs on the Pharmaceutical Benefits Scheme.

Health Minister Mark Butler has confirmed drugs including Ocrevus (ocrelizumab) and Kesimpta (ofatumumab) will remain listed on the PBS while an urgent review of MS medicines is carried out, easing weeks of anxiety for patients, their families and clinicians.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.